KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC) Meeting Abstract
| Authors: | Rudin, C. M.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csoszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Czyzewicz, G.; Yang, J. C. H.; Mazieres, J.; Orlandi, F. J.; Luft, A.; Gumus, M.; Kato, T.; Kalemkerian, G. P.; Luo, Y.; Pietanza, M. C.; Kim, H. R. |
| Abstract Title: | KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368303337 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.9001 |
| Notes: | Meeting Abstract: 9001 -- Source: Wos |
